Page last updated: 2024-10-30

meprobamate and Pre-Eclampsia

meprobamate has been researched along with Pre-Eclampsia in 1 studies

Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)

Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ERMIGLIA, G1

Other Studies

1 other study available for meprobamate and Pre-Eclampsia

ArticleYear
[Further notes on meprobamate in obstetrics and gynecology; therapeutic effectiveness of rectal administration].
    Minerva ginecologica, 1958, Mar-15, Volume: 10, Issue:5

    Topics: Administration, Rectal; Female; Genital Diseases, Female; Gynecology; Humans; Meprobamate; Obstetric

1958